Pyrrolidone

DB19152ExperimentalSmall molecule

Pyrrolidone is under investigation in clinical trial NCT05444998 (Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for Her2+breast Cancer).

Chemical structure of Pyrrolidone
Formula / weight
C4H7NO · 85.106 g/mol (avg)
Also known as
.alpha.-pyrrolidone · 2-pyrrolidinone · 2-pyrrolidone · 2-tetrahydropyrrolone · Butyrolactam
Code names
FEMA NO. 4829 · NSC-4593 · NSC-8413

Resolves to

Compound
UNIIKKL5D39EOLCAS616-45-5ChEMBLCHEMBL276849ChEBI36592
Clinical / RWD
RxNorm1358473
Structure
InChIKeyHNJBEVLQSNELDL-UHFFFAOYSA-NSMILESO=C1CCCN1
Targets
Q9NXJ5PGPEP1

What you can answer from here — as of September 14, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Pyrrolidone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In